Joan M Gates, MD
Emergency Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gates’s office at (650) 948-4981 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G37742 · Current
Licensed to practise in California · since 1978 · expires 2028-06-30 · University of Texas Medical School at San Antonio.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$34,679
Medicare paid this office $34,679 for 52 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of muscle and/or tissue, 20.0 sq cm or less | 28 | $13,946 | $137 |
| Return visit (30+ min) | 35 | $12,404 | $87 |
| New patient visit (60+ min) | 19 | $3,071 | $162 |
Procedures Medicare counted
| Removal of tissue | 181 | More than 90% of doctors who do this |
Who their Medicare patients are
52 Original Medicare patients in 2024. Average age 72 · Under 65 21% · 85 and older 25% · Women 40% · Also on Medicaid 77% · Health risk score 3.91. Sicker patients than 9 in 10 peers; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 75% · Diabetes 58% · Chronic kidney disease 42% · Depression 38% · Heart failure 33% · Dementia 33% · Coronary heart disease 31% · Atrial fibrillation 29% · Stroke 23%.
The office billed $96,491, Medicare allowed $43,581 and paid $34,679; for 323 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 52 | 323 | 72 | 3.91 | $96,491 | $34,679 |
| 2023 | 79 | 675 | 69 | 3.61 | $200,905 | $71,136 |
| 2022 | 55 | 540 | 71 | 3.79 | $155,043 | $55,436 |
| 2021 | 83 | 645 | 71 | 3.38 | $190,511 | $70,391 |
| 2020 | 107 | 880 | 73 | 4.10 | $266,685 | $87,492 |
| 2019 | 130 | 1,136 | 76 | 3.61 | $344,836 | $107,790 |
| 2018 | 132 | 1,224 | 76 | 3.85 | $335,878 | $107,174 |
| 2017 | 136 | 1,240 | 76 | 3.78 | $362,847 | $113,419 |
| 2016 | 137 | 1,126 | 77 | 3.11 | $348,566 | $106,737 |
| 2015 | 171 | 1,210 | 76 | 2.92 | $381,104 | $122,579 |
| 2014 | 138 | 1,067 | 75 | 3.46 | $314,910 | $105,258 |
| 2013 | 154 | 1,515 | 76 | 3.07 | $417,948 | $133,929 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 37 | $25,157 | $137 |
| Return visit (30+ min) | 52 | $23,124 | $88 |
| New patient visit (60+ min) | 46 | $7,481 | $163 |
| Long return visit (40+ min) | 13 | $2,079 | $130 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $1,861 | $55 |
| Short return visit (20+ min) | 17 | $1,669 | $60 |
2022: 5 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 31 | $22,582 | $139 |
| Return visit (30+ min) | 39 | $20,401 | $90 |
| New patient visit (60+ min) | 18 | $2,990 | $166 |
| Short return visit (20+ min) | 22 | $2,622 | $61 |
| Removal of skin and tissue, 20.0 sq cm or less | 12 | $1,558 | $56 |
2021: 6 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 37 | $27,310 | $142 |
| Return visit (30+ min) | 55 | $23,741 | $92 |
| New patient visit (60+ min) | 40 | $6,804 | $170 |
| Short return visit (20+ min) | 26 | $2,611 | $62 |
| Long return visit (40+ min) | 17 | $2,440 | $136 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $1,859 | $56 |
2020: 8 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 59 | $34,747 | $142 |
| Return visit (30+ min) | 69 | $17,123 | $73 |
| Management of oxygen chamber therapy | 13 | $14,565 | $99 |
| New patient visit (60+ min) | 51 | $7,823 | $153 |
| Short return visit (20+ min) | 38 | $3,515 | $47 |
| Long return visit (40+ min) | 17 | $1,933 | $102 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $1,405 | $56 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 11 | $1,111 | $46 |
2019: 10 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 70 | $40,606 | $133 |
| Management of oxygen chamber therapy | 23 | $23,595 | $93 |
| Return visit (30+ min) | 64 | $10,997 | $67 |
| New patient visit (60+ min) | 49 | $7,059 | $144 |
| Short return visit (20+ min) | 51 | $4,743 | $44 |
| Return visit (30+ min) | 17 | $1,969 | $68 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 15 | $1,827 | $47 |
| New patient visit (45+ min) | 16 | $1,765 | $110 |
| Long return visit (40+ min) | 14 | $1,624 | $96 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $865 | $54 |
2018: 11 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 75 | $38,071 | $133 |
| Management of oxygen chamber therapy | 23 | $26,054 | $92 |
| Return visit (30+ min) | 67 | $13,610 | $65 |
| New patient visit (60+ min) | 58 | $8,257 | $142 |
| Short return visit (20+ min) | 56 | $6,559 | $43 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 24 | $3,409 | $47 |
| Long return visit (40+ min) | 25 | $3,129 | $95 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 13 | $1,870 | $72 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $1,518 | $54 |
| New patient visit (45+ min) | 12 | $1,131 | $94 |
| Short return visit | 18 | $606 | $22 |
2017: 9 services
| Management of oxygen chamber therapy | 26 | $36,956 | $92 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 68 | $36,929 | $130 |
| Return visit (30+ min) | 69 | $15,841 | $66 |
| New patient visit (60+ min) | 46 | $5,918 | $129 |
| Short return visit (20+ min) | 47 | $4,294 | $43 |
| Long return visit (40+ min) | 32 | $4,282 | $86 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 19 | $1,716 | $46 |
| New patient visit (45+ min) | 13 | $1,388 | $107 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $806 | $50 |
2016: 8 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 63 | $37,752 | $124 |
| Management of oxygen chamber therapy | 17 | $26,493 | $92 |
| Return visit (30+ min) | 73 | $15,674 | $66 |
| Long return visit (40+ min) | 56 | $8,782 | $94 |
| New patient visit (60+ min) | 54 | $7,078 | $131 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 16 | $2,113 | $64 |
| Short return visit (20+ min) | 21 | $1,532 | $44 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $867 | $54 |
2015: 8 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 79 | $47,296 | $134 |
| Management of oxygen chamber therapy | 27 | $28,454 | $94 |
| Return visit (30+ min) | 81 | $19,068 | $67 |
| New patient visit (60+ min) | 82 | $11,863 | $145 |
| Long return visit (40+ min) | 34 | $4,466 | $95 |
| Short return visit (20+ min) | 47 | $2,898 | $43 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 12 | $1,790 | $72 |
| New patient visit (45+ min) | 16 | $1,782 | $111 |
2014: 8 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 59 | $33,386 | $132 |
| Management of oxygen chamber therapy | 20 | $27,856 | $105 |
| Return visit (30+ min) | 86 | $19,073 | $67 |
| New patient visit (60+ min) | 68 | $9,882 | $145 |
| Short return visit (20+ min) | 36 | $3,864 | $41 |
| Long return visit (40+ min) | 17 | $2,224 | $97 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 13 | $1,271 | $71 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $1,263 | $51 |
2013: 9 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 51 | $38,207 | $133 |
| Management of oxygen chamber therapy | 30 | $36,126 | $102 |
| Return visit (30+ min) | 65 | $15,296 | $65 |
| Short return visit (20+ min) | 80 | $11,515 | $42 |
| New patient visit (60+ min) | 71 | $9,748 | $137 |
| Removal of skin and tissue, 20.0 sq cm or less | 57 | $8,367 | $55 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 23 | $2,856 | $63 |
| New patient visit (45+ min) | 24 | $2,478 | $103 |
| Long return visit (40+ min) | 13 | $1,177 | $91 |
Medicaid work
$2,781 in 2024
Medicaid paid $2,781 for 429 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 61 | $1,432 |
| Service | 41 | $892 |
| Service | 94 | $458 |
| Medication list documented in medical record (COA) | 89 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 20 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 26 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 83 | $0 |
| Return visit (30+ min) | 15 | $0 |
| 2024 | 429 | 8 | 23 | $2,781 |
| 2023 | 94 | 3 | 16 | $206 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 38 | $206 |
| Service | 39 | $0 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 17 | $0 |
Drugs they prescribed that Part D paid
$1,202
Pharmacies billed $1,202 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 97) in 2024. At or below the middle of the specialty; the typical emergency medicine clinician is at 12%.
95 generic and fewer than 11 brand-name prescriptions · $1,202 in drug cost · 29 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mupirocin | 36 | $239 | $7 |
| Sulfamethoxazole-Trimethoprim | 13 | $26 | $2 |
Year by year
| 2024 | 97 | 38 | 0% (0) | None | $1,202 |
| 2023 | 89 | 39 | 0% (0) | None | $1,524 |
| 2022 | 68 | 22 | 0% (0) | None | $2,487 |
| 2021 | 53 | 21 | 0% (0) | None | $2,069 |
| 2020 | 110 | 43 | 0% (0) | None | $2,571 |
| 2019 | 112 | 50 | None | None | $2,717 |
| 2018 | 100 | 44 | None | None | $2,862 |
| 2017 | 138 | 60 | None | None | $3,905 |
| 2016 | 142 | 57 | None | None | $4,024 |
| 2015 | 168 | 61 | 0% (0) | 7% | $4,178 |
| 2014 | 119 | 61 | 0% (0) | None | $4,102 |
| 2013 | 161 | 67 | None | None | $13,094 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Mupirocin | 40 | $448 | $11 |
2022: 1 drug
| Mupirocin | 32 | $236 | $7 |
2021: 1 drug
| Mupirocin | 17 | $150 | $9 |
2020: 2 drugs
| Mupirocin | 37 | $259 | $7 |
| Sulfamethoxazole-Trimethoprim | 15 | $117 | $8 |
2019: 2 drugs
| Mupirocin | 36 | $330 | $9 |
| Cephalexin | 13 | $198 | $15 |
2018: 1 drug
| Mupirocin | 25 | $270 | $11 |
2017: 2 drugs
| Mupirocin | 61 | $609 | $10 |
| Sulfamethoxazole-Trimethoprim | 13 | $193 | $15 |
2016: 3 drugs
| Nystop | 14 | $446 | $32 |
| Mupirocin | 39 | $427 | $11 |
| Lidocaine-Prilocaine | 11 | $255 | $23 |
2015: 3 drugs
| Mupirocin | 58 | $544 | $9 |
| Dicloxacillin | 14 | $518 | $37 |
| Clotrimazole | 11 | $110 | $10 |
2014: 3 drugs
| Nystop | 12 | $782 | $65 |
| Dicloxacillin | 18 | $487 | $27 |
| Mupirocin | 27 | $318 | $12 |
2013: 4 drugs
| Mupirocin | 47 | $671 | $14 |
| Gentamicin Sulfate | 23 | $443 | $19 |
| Dicloxacillin | 13 | $433 | $33 |
| Sulfamethoxazole-Trimethoprim | 13 | $194 | $15 |
Money from drug and device companies
$35 in 2025
| 2025 | 1 | 1 | None | $35 |
| 2022 | 1 | 3 | None | $187 |
| 2020 | 1 | 1 | None | $23 |
| 2019 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Grafix | $35 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2025-09-05 | Grafix | $35 |
See earlier years (2022, 2020, 2019)
2022: $187
| Organogenesis | Puraply | $187 | 3 payments
|
2020: $23
| Smith+Nephew | Grafix Pl | $23 | 1 payment
|
2019: $17
| Organogenesis | Apligraf | $17 | 1 payment
|
Professional record
- NPI
- 1245213727
- Licence
- CA G37742California G37742: Current · expires 2028-06-30
- Trained
- University of Texas Medical School at San Antonio, 1977
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207P00000X (207P00000X)
- Mailing address
- 25400 La Rena Ln, Los Altos Hills, CA, 94022
- NPI first listed
- 2005-11-29
- NPI last updated
- 2010-08-30
This is when the NPI record was last certified, not a medical board exam.